Blades MC, Manzo A, Ingegnoli F, Taylor PR, Panayi GS, Irjala H, Jalkanen S, Haskard DO, Perretti M, Pitzalis C:
Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice.
J Immunol
2002;168:4308-4317.
Bronzwaer SLAM, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJW, Degener JE, participants :
A European study on the relationship between antimicrobial use and antimicrobial resistance.
Emerging Infectious Diseases
2002;8:278-282.
Ekman P, Saarinen M, He Q, Gripenberg-Lerche C, Grönberg A, Arvilommi H, Granfors K:
HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines.
Infect Immun
2002;70:1609-1614.
Granfors K, Märker-Hermann E, Keyser F, Khan MA, Veys EM, Yu DTY:
The cutting edge of spondylarthropathy research in the Millennium.
Arthritis Rheum
2002;46:606-613.
Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH:
Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.
Lancet
2002;359:150-157.
Hakanen A, Huovinen P, Kotilainen P, Siitonen A, Jousimies-Somer H:
Quality control strains used in susceptibility testing of Campylobacter spp.
J Clin Microbiol
2002;40:2705-2706.
Hakanen A, Jalava J, Kotilainen P, Jousimies-Somer H, Siitonen A, Huovinen P:
gyrA polymorphism in Campylobacter jejuni: Detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing.
Antimicrob Agents Chemother
2002;46:2644-2647.
Huhtinen M, Laasila K, Granfors K, Puolakkainen M, Seppälä I, Laasonen L, Repo H, Karma A, Leirisalo-Repo M:
Infectious background of patients with a history of acute anterior uveitis.
Ann Rheum Dis
2002;61:1012-1016.
Janatuinen T, Friberg J, Viljanen MK, Raitakari OT, Nuutila P, Vainionpää R, Oksi J, Peltonen R, Engblom E, Laine H, Knuuti J:
Early impairment of coronary flow reserve is not associated with Chlamydia pneumomiae antibodies .
Ann Med
2002;34:284-290.
Kataja J, Huovinen P, Efstratiou A, Pérez-Trallero E, Seppälä H, The Macrolide Resistance Study Group:
Clonal relationships among isolates of Erythromycin-resistant Streptococcus pyogenes of different geographical origin.
Eur J Clin Microbiol Infect Dis
2002;21:589-595.
Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams DH:
Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
J Immunol
2002;169:983-992.
Leistevuo J, Leistevuo T, Helenius H, Pyy L, Huovinen P, Tenovuo J:
Mercury in saliva and the risk exceeding limits for sewage in relation to exposure to amalgam fillings.
Arch Environ Health
2002;57:366-370.
Mäkinen J, Mertsola J, Viljanen MK, Arvilommi H, He Q:
Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis.
J Clin Microbiol
2002;40:2213-2216.
Mäkinen J, Sarkola A, Marjamäki M, Viljanen MK, Soini H:
Evaluation of GenoType and LiPA mycobacteria assays for identification of Finnish mycobacterial isolates.
J Clin Microbiol
2002;40:3478-3481.
Peltomaa M, Pyykkö I, Seppälä I, Viljanen M:
Lyme borreliosis and facial paralysis-A prospective analysis of risk factors and outcome.
AM J OTOLARYNGOL
2002;23:125-132.
Penttinen MA, Holmberg CI, Sistonen L, Granfors K:
HLA-B27 modulates nuclear factor kappaB activation in human monocytic cells exposed to lipopolysaccharide.
Arthritis Rheum
2002;46:2172-2180.
Penttinen MA, Liu Y, Granfors K:
The role of infection in the pathogenesis of spondyloarthropathies with special reference to human leukocyte antigen-B27.
Current Rheumatology Reports
2002;4:518-524.
Pihlajamäki M, Kaijalainen T, Huovinen P, Jalava J, The Finnish Study Group for Antimicrobial Resistance:
Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000.
J Antimicrob Chemother
2002;49:785-792.
Pihlajamäki M, Kataja J, Seppälä H, Elliot J, Leinonen M, Huovinen P, Jalava J:
Ribosomal mutations in Streptococcus pneumoniae clinical isolates.
Antimicrob Agents Chemother
2002;46:654-658.
Rantakokko-Jalava K, Jalava J:
Optimal DNA isolation method for detection of bacteria in clinical specimens by broad-range PCR.
J Clin Microbiol
2002;40:4211-4217.
Saarinen M, Ekman P, He Q, Ikeda M, Virtala M, Yu DTY, Arvilommi H, Granfors K:
Elimination of Salmonella enterica serotype Enteritidis in intestinal epithelial cells by mechanisms other than nitric oxide.
J Med Microbiol
2002;51:13-19.
Saarinen M, Ekman P, Ikeda M, Virtala M, Grönberg A, Yu DTY, Arvilommi H, Granfors K:
Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27.
Rheumatology
2002;41:651-657.
Salmi M, Jalkanen S:
Enzymatic control of leukocyte trafficking: Role of VAP-1.
ADV EXP MED BIOL
2002;512:57-63.
Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, Knip M, Jalkanen S, Salomaa V:
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.
AM J PATHOL
2002;161:2255-2262.
Wang J, Yang Y, Li J, Mertsola J, Arvilommi H, Yuan L, Shen X, He Q:
Infantile pertussis rediscovered in China.
Emerging Infectious Diseases
2002;8:859-861.
Yegutkin GG, Henttinen T, Samburski SS, Spychala J, Jalkanen S:
The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells.
Biochem J
2002;367:121-128.
B. Original articles and reviews published in domestic languages
Huovinen P:
Bakteerien lääkeresistenssin torjunta Suomessa.
Kansanterveys - the Bulletin of National Public Health Institute of Finland
2002(7):4,9.
Huovinen P:
Julkaisusarjojen Mersut ja Ladat.
Erikoislääkäri
2002;12:25-29.
Huovinen P, Hakanen A, Kotilainen P, Jousimies-Somer H, Siitonen A:
Salmonellojen ja kampylobakteerien resistenssi otettava huomioon hoidossa.
Kansanterveys - the Bulletin of National Public Health Institute of Finland
2002(1):7-8.
Huovinen P, Kaukoranta H, Katila M, Nissinen A, Vaara M, FiRe-verkosto:
Avohoidon potilaista eristettyjen bakteerien lääkeresistenssi Suomessa 1997-2000.
Suom Lääkäril
2002;57:21-26.
Ruuskanen O, Huovinen P:
Jättääkö aika penisilliinistä?
Duodecim
2002;118:325-327.
Soini H:
DNA-sekvensointi bakteerien tunnistuksessa - esimerkki mykobakteerilaboratoriosta.
Moodi
2002;26:111-112.
C. Textbooks and chapters in textbooks, reports and proceedings
Mertsola J, He Q:
Bordetella pertussis (Whooping Cough) and other species.
In: Yu VL, Weber R, Raoult D, Rex JH, Shafer RW, White NJ, Treanor JJ, Seenivasan MH ed. Antimicrobial Therapy and Vaccines, Volume I: Microbes, second edition. New York: Apple Trees Productions, LLC, 2002:93-101.
Mäkinen J, He Q, Viljanen MK:
Genospecies-specific melting temperature of the recA PCR product for the detection of Borrelia burgdorferi sensu lato and differentiation of Borrelia garinii from Borrelia afzelii and Borrelia burgdorferi .
In: Reischl U, Wittwer C, Cockerill F ed. Rapid Cycle Real-Time PCR - Methods and Applications: Microbiology and Food Analysis. Heidelberg: Springer-Verlag , 2002:139-147.
D. Other publications
Huovinen P:
Macrolide-resistant group A streptococcus - now in the United States.
N Engl J Med
2002;346:1243-1245.
E. Theses
Hakanen A:
Fluoroquinolone resistance in Salmonella enterica and Campylobacter jejuni [dissertation].
Turku: Turun Yliopisto, 2002. 121 p. (D. Medica-Odontologica 504/2002).
Irjala H:
An immunotherapeutic approach to cancer of the head and neck [dissertation].
Turku: Turun Yliopisto, 2002. 104 p. (D. Medica-Odontologica 527/2002).
Leistevuo J:
Dental amalgam fillings: Inorganic and organic mercury in the oral and gastrointestinal environment [dissertation].
Turku: Turun Yliopisto, 2002. 128 p. (D. Medica-Odontologica 480/2002).
Pihlajamäki M:
Antimicrobial resistance in Streptococcus pneumoniae, with special reference to macrolide resistance [dissertation].
Turku: Turun Yliopisto, 2002. 105 p. (D. Medica-Odontologica 521/2002).